Intermittent Claudication Market Overview 2025: Size, Share & Growth Analysis

30 Apr, 2025

The Intermittent Claudication Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.

What are the Historical Growth Trends in the Intermittent Claudication Market?

The historical growth trend in the Intermittent Claudication Global Market Report 2025 market shows a strong increase. The market size was $12.81 billion in 2024 and is projected to reach $13.64 billion in 2025, growing at a compound annual growth rate (CAGR) of 6.5%.

What are the 2025 Market Projections: Forecasted Size & Growth Rate for the Intermittent Claudication Industry?

The intermittent claudication market is projected to reach $17.39 billion in 2029, growing at a compound annual growth rate (CAGR) of 6.2%.

Download Your Free Sample of the 2025 Intermittent Claudication Market Report and Uncover Key Trends Now!

What are the Key Growth Drivers Fueling the Intermittent Claudication Market?

The key drivers in the intermittent claudication market are:

• Rising prevalence of diabetes and obesity
• Increasing cases of cardiovascular diseases
• Increase in alcohol and tobacco consumption
• Growth in healthcare spending

Global Market Segmentation: Identifying Major Intermittent Claudication Industry Segments

The intermittent claudication market covered in this report is segmented –
1) By Type: Medication Therapies, Revascularization
2) By Route Of Administration: Parenteral Route, Oral Route, Other Routes Of Administration
3) By Application: Hospitals, Clinics, Home Healthcare, Other Applications
4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies Subsegments:
1) By Medication Therapies: Antiplatelet Agents, Vasodilators, Phosphodiesterase Inhibitors, Cilostazol, Pentoxifylline
2) By Revascularization: Angioplasty, Stenting, Bypass Surgery, Endarterectomy

Pre-order the 2025 Intermittent Claudication Global Market Report for Fast Delivery & Comprehensive Insights!

What are the emerging Trends Shaping the Future of the Intermittent Claudication Market?

The key trends in the intermittent claudication market are:

• Advancements in peripheral artery disease diagnostics are shaping the future of the market.
• The integration of wearable devices is becoming a trend.
• Personalized medicine integration is a significant emerging trend.
• There is a shift towards the use of drug-eluting stents and advancements in stem cell therapy.

Who Are the Top Competitors & Leading Players in the Intermittent Claudication Market?

Major players in the intermittent claudication market are:

• Pfizer Inc.
• Bristol Myers Squibb Company
• AstraZeneca PLC
• Novartis AG
• GSK plc
• Eli Lilly and Company
• Merck KGaA
• Teva Pharmaceutical
• Otsuka Pharmaceutical Co. Ltd.
• Sanofi S.A.
• Bayer AG
• Hikma Pharmaceuticals PLC
• Dr. Reddy's Laboratories
• Pipelinepharma
• Pharmaoffer
• Alkem Laboratories
• LGM Pharma
• Aastrid Life Sciences Pvt. Ltd.
• Manus Aktteva Biopharma LLP
• Enomark Pharma
• Pharmacompass.

Regional Dominance: Which Area Leads the Global Template Market?

North America was the largest region in the intermittent claudication market in 2024